The global laboratory information management system market size was valued at USD 2.3 billion in 2023 and is expected to expand at a compound annual growth rate (CAGR) of 6.48% from 2024 to 2030. Technological advancements pertinent to pharmaceutical laboratories and a rise in demand for lab automation are expected to fuel the demand for these systems in the coming years. Advancements in R&D labs, especially in pharmaceutical and biotechnological laboratories, are expected to enable positive industry growth.
In addition, low cost of implementation, efficient time management, and compliance with GDP, GCP & GMP are other major factors driving Laboratory Information Management System (LIMS) industry growth.
Collaborations, partnerships, acquisitions, and product approvals & launches have significantly impacted the market in recent years. Furthermore, there has been a significant rise in the demand for LIMS due to its increasing awareness, which, in turn, is fueling market growth. Rising automation in laboratories, increasing demands of regulatory compliance, technological advancements in LIMS, growing awareness through conferences, workshops, and seminars, and increasing R&D expenditure are also among the major factors driving global market growth.
During the COVID-19 pandemic, demand for 24/7 laboratory testing services experienced a surge. Moreover, clinical laboratories were operating at full capacity, which resulted in significant stress on laboratory personnel as well as the laboratory infrastructure. Such stressful environments are very undesirable, especially when laboratories are equipped with a large number of dangerous chemicals capable of causing biohazards every day. This, in turn, encourages the implementation of LIMS solutions to streamline workflows by global benchmarks.
Based on product, it has been segmented into on-premise, web-hosted, and cloud-based sub-segments. Technical considerations are of utmost importance when purchasing any laboratory informatics solution. Organizations assess the requirements of solutions as well as their IT infrastructure. This aids organizations in choosing between web-based, on-premise, and cloud-based solutions.
Cloud-based product segment dominated the market, accounting for a global revenue share of over 43% in 2023. The segment is estimated to retain its leading position growing at the fastest CAGR over the forecast period. Data can be accessed from multiple and virtually infinite number of access points. In a growing remote work culture, the flexibility offered by features such as virtual access points remains a key factor aiding the cloud-based product segment's dominance. In addition, reduced IT manpower, cost-effective data management, and easy deployability are other factors that help drive segment growth.
The web-hosted segment accounted for the second-largest revenue share due to high adoption of web-hosted LIMS among consumers. These LIMS solutions are suitable for various laboratories, including R&D departments, manufacturing companies, public utilities, and environmental, chemical, contract, and QC labs. On-premise segment is also expected to grow at a significant CAGR from 2023 to 2030 as it is more customizable and reliable as compared to other LIMS services and, thus, expected to gain more popularity in coming years.
Based on components, the market is bifurcated into software and services. The services segment dominated the LIMS market and accounted for more than 58% share of the global revenue in 2023. This is due to an increase in the need for LIMS implementation, integration, maintenance, validation, and support. Moreover, high demand for LIMS outsourcing solutions is expected to drive segment growth.
Large pharmaceutical research labs often witness a lack of resources and skills required for the deployment of analytics. Thus, these services are outsourced. This outsourcing can be short-term, project-based, or long-term contracts. These services are offered in the form of packages, and these packages include compliance with promotional spending, social media analytics, predictive analytics for medical device failure, benchmarking services, and others.
The software segment is expected to show steady growth over the forecast period due to advancements of software systems from SaaS to more advanced PaaS, CaaS, and community networks. Many market players are constantly adopting different strategies to promote market growth. For instance, in May 2021, LabVantage Solutions launched a new innovative analytics solution, a new certified SaaS solution, and an update to its LIMS Platform.
Based on end-use, it has been divided into life sciences, Contract Research Organizations (CROs), petrochemical refineries and oil & gas, chemical, food & beverage & agriculture industry, and environmental testing laboratories, among others. Other sector sub-segments include industries including forensics, and metal & mining laboratories. Life sciences accounted for the largest share of more than 40% of the global revenue in 2023. This is owing to the high adoption of LIMS in pharmaceutical laboratories. Lack of skilled staff, demand for higher productivity, cost efficiency, and increasing demand for biobanks and biorepositories are expected to bolster the growth of this segment.
The Contract Research Organizations (CROs) segment is expected to register the fastest growth rate from 2024 to 2030. This rapid growth can be attributed to the increase in demand for outsourcing by pharmaceutical and biotechnological companies. Various associated advantages such as cost efficiency, a necessity to maintain focus on core competencies, and mutual benefits to both contractor &client, are anticipated to drive segment growth over the forecast period.
North America accounted for the highest revenue share of more than 44% in 2023. The dominance is due to supportive policies facilitating laboratory automation adoption, such as EHR programs. In addition, the presence of advanced infrastructure, increasing demand for genomic studies, and increased government funding are some other factors responsible for a high share of this region.
The LIMS industry in Asia Pacific is expected to exhibit lucrative growth during the forecast period owing to an increase in demand for CROs providing LIMS. Emerging economies such as India and Japan remain prime outsourcing hubs due to the availability of skilled manpower and low costs. Moreover, several biopharma players are shifting their manufacturing plants to Asia Pacific for low-cost production. This is creating significant demand for LIMS in Asian countries.
Nevertheless, the COVID-19 pandemic pressured stakeholders from developed markets, such as the U.S. and Europe, to reduce their heavy dependence on Asian countries and shift back to in-house operations. China, Singapore, India, Brazil, Japan, and Middle Eastern countries are major upcoming markets for LIMS. These markets are home to lackluster government regulations and international standards, thus, providing immense potential for vendors that can meet the standards implemented in developed countries, such as the U.S.
The global LIMS industry remains highly competitive. Key companies are involved in acquisitions, strategic collaborations, and new product launches to withstand the competition. Companies are focusing on implementing strategies, such as new product launches, regional expansion, partnerships, and distribution agreements, to increase their revenue share.
In August 2023, Thermo Fisher Scientific, Inc. launched the EXENT solution, a fully integrated and automated mass to meet the unmet clinical needs for innovative mass spectrometry solutions to transform monoclonal gammopathy management.
In December 2022, LabVantage Solutions, Inc. released Version 8.8 of its flagship LIMS platform, which features a multitude of upgrades across all components. These factors are expected to boost the growth of the market over the forecast period.
Report Attribute |
Details |
Market size value in 2024 |
USD 2.4 billion |
Revenue forecast in 2030 |
USD 3.5 billion |
Growth Rate |
CAGR of 6.5% from 2024 to 2030 |
Base year for estimation |
2023 |
Actual estimates/Historical data |
2018 - 2022 |
Forecast period |
2024 - 2030 |
Quantitative units |
Revenue in USD million, CAGR from 2024 to 2030 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, trends |
Segments covered |
Product, component, end-use, region |
Regions covered |
North America; Europe; Asia Pacific; Latin America; MEA |
Country Scope |
U.S.; Canada; U.K.; Germany; Italy; France; Spain; Sweden; Denmark; Norway; Japan; China; India; Australia; South Korea; Thailand; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE; Kuwait |
Key companies profiled |
Thermo Fisher Scientific Inc.; Siemens; LabVantage Solutions Inc.; LabWare; PerkinElmer Inc.; Abbott; Autoscribe Informatics; Illumina, Inc.; Labworks; LabLynx, Inc.; Computing Solutions, Inc.; CloudLIMS.com (LabSoft LIMS); Ovation; LABTRACK; AssayNet Inc. |
Customization scope |
Free report customization (equivalent up to 8 analysts’ working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at the global, regional & country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global laboratory information management system market report based on product, component, end-use, and region:
Product Outlook (Revenue, USD Million, 2018 - 2030)
On-premise
Web-hosted
Cloud-based
Component Outlook (Revenue, USD Million, 2018 - 2030)
Software
Services
End-use Outlook (Revenue, USD Million, 2018 - 2030)
Life Sciences
CROs
Petrochemical Refineries & Oil and Gas Industry
Chemical Industry
Food and Beverage & Agriculture Industries
Environmental Testing Laboratories
Other Industries (Forensics and Metal & Mining Laboratories)
Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Sweden
Denmark
Norway
Asia Pacific
China
India
Japan
Australia
South Korea
Thailand
Latin America
Brazil
Mexico
Argentina
MEA
South Africa
Saudi Arabia
UAE
Kuwait
b. The global laboratory information management system market size was estimated at USD 2.3 billion in 2023 and is expected to reach USD 2.4 billion in 2024.
b. The global laboratory information management system market is expected to grow at a compound annual growth rate of 6.48% from 2024 to 2030 to reach USD 3.5 billion by 2030.
b. The cloud-based segment dominated the global LIMS market and accounted for the largest revenue share of over 43.4% in 2023.
b. The services segment led the global laboratory information management system market and accounted for the largest revenue share of over 58.4% in 2023.
b. The life sciences segment dominated the global LIMS market and accounted for the largest revenue share of over 40.8% in 2023.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."